Loading...
Monitoring Toxicity, Impact, and Adherence of Hydroxyurea in Children with Sickle Cell Disease
Hydroxyurea (HU) is underutilized in sickle cell disease (SCD). Patient adherence with taking HU and with required drug monitoring is a provider perceived barrier to HU utilization.(1-4) To determine process issues that may contribute to these barriers we sought to: 1) describe how providers monitor...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3804029/ https://ncbi.nlm.nih.gov/pubmed/21815183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.22101 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|